Orchid Pharma Ltd
Company Profile
Business description
Orchid Pharma Ltd is involved in the development, manufacturing, and marketing of diverse bulk actives, formulations, and nutraceuticals. The company operates in one business segment which is Cephalosporin Pharmaceuticals, in which the Company drives its major sales through Active Pharmaceuticals Ingredients. The company produces various products for cardiovascular, anti-diabetic, neuropsychiatry, veterinary, non-antibiotics, and cephalosporins. The products are grouped under formulations and active pharmaceutical ingredients. The company operates its business throughout the Indian region.
Contact
Sector 74A
15th Floor, Tower-1, DLF Corporate Greens
Narsinghpur
GurugramHR122004
INDT: +91 4428211000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2025
Employees
923
Stocks News & Analysis
video
What does the RBA rate cut mean for investors?
stocks
Insights from reporting season: So far, so good
stocks
3 cheap ASX stocks owned by top rated funds
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,570.90 | 30.80 | -0.36% |
CAC 40 | 8,154.51 | 31.93 | 0.39% |
DAX 40 | 22,287.56 | 27.09 | -0.12% |
Dow JONES (US) | 43,428.02 | 748.63 | -1.69% |
FTSE 100 | 8,659.37 | 3.60 | -0.04% |
HKSE | 23,477.92 | 900.94 | 3.99% |
NASDAQ | 19,524.01 | 438.36 | -2.20% |
Nikkei 225 | 38,776.94 | 98.90 | 0.26% |
NZX 50 Index | 12,752.58 | 127.78 | -0.99% |
S&P 500 | 6,013.13 | 104.39 | -1.71% |
S&P/ASX 200 | 8,296.20 | 26.60 | -0.32% |
SSE Composite Index | 3,379.11 | 28.33 | 0.85% |